TY - JOUR
T1 - Comparison of the rates of adverse drug reactions
T2 - Ionic contrast agents, ionic agents combined with steroids, and nonionic agents
AU - Wolf, Gerald L.
AU - Mishkin, Mark M.
AU - Roux, Susan G.
AU - Halpern, Elkan F.
AU - Gottlieb, Janis
AU - Zimmerman, Jay
AU - Gillen, Joe
AU - Thellman, Cheryl
PY - 1991/5
Y1 - 1991/5
N2 - The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989.Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (< .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agents: < .001), moderate (1.2% versus 0.1%; < .001), or severe (0.37 % versus 0.01%; < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly beTTER with respect to mild reactions (2.9% versus 0.4%, < .001), moderate reactions (0.9% versus 0.1%, < .01), and severe reactions (0.25% versus 0.01%, < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid Premedication.
AB - The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989.Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (< .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agents: < .001), moderate (1.2% versus 0.1%; < .001), or severe (0.37 % versus 0.01%; < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly beTTER with respect to mild reactions (2.9% versus 0.4%, < .001), moderate reactions (0.9% versus 0.1%, < .01), and severe reactions (0.25% versus 0.01%, < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid Premedication.
KW - Adverse effects
KW - Contrast media
KW - Ionic agents
KW - Nonionic agents
KW - Steroid premedication
UR - http://www.scopus.com/inward/record.url?scp=0025882585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025882585&partnerID=8YFLogxK
U2 - 10.1097/00004424-199105000-00003
DO - 10.1097/00004424-199105000-00003
M3 - Article
C2 - 2055736
AN - SCOPUS:0025882585
SN - 0020-9996
VL - 26
SP - 404
EP - 410
JO - Investigative radiology
JF - Investigative radiology
IS - 5
ER -